These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35862018)

  • 21. Natamycin niosomes as a promising ocular nanosized delivery system with ketorolac tromethamine for dual effects for treatment of candida rabbit keratitis; in vitro/in vivo and histopathological studies.
    El-Nabarawi MA; Abd El Rehem RT; Teaima M; Abary M; El-Mofty HM; Khafagy MM; Lotfy NM; Salah M
    Drug Dev Ind Pharm; 2019 Jun; 45(6):922-936. PubMed ID: 30744431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amphotericin B nanohydrogel ocular formulation using alkyl glyceryl hyaluronic acid: Formulation, characterization, and in vitro evaluation.
    Banshoya K; Fujita C; Hokimoto Y; Ohnishi M; Inoue A; Tanaka T; Kaneo Y
    Int J Pharm; 2021 Dec; 610():121061. PubMed ID: 34481008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients.
    Li L; Wang Z; Li R; Luo S; Sun X
    Am J Ophthalmol; 2008 Nov; 146(5):724-8. PubMed ID: 18707669
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Oliveira Dos Santos C; Kolwijck E; van der Lee HA; Tehupeiory-Kooreman MC; Al-Hatmi AMS; Matayan E; Burton MJ; Eggink CA; Verweij PE
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benefit of polyhexamethylene biguanide in Fusarium keratitis.
    Behrens-Baumann W; Seibold M; Hofmüller W; Walter S; Haeberle H; Wecke T; Tammer I; Tintelnot K
    Ophthalmic Res; 2012; 48(4):171-6. PubMed ID: 22710976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Necessity to identify the causative agent for appropriate treatment in fungal corneal ulcer: an in vitro study.
    Gupta MK; Chandra A; Prakash P; Tilak R
    J Mycol Med; 2018 Mar; 28(1):201-205. PubMed ID: 29398639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amphotericin B-silver hybrid nanoparticles: synthesis, properties and antifungal activity.
    Tutaj K; Szlazak R; Szalapata K; Starzyk J; Luchowski R; Grudzinski W; Osinska-Jaroszuk M; Jarosz-Wilkolazka A; Szuster-Ciesielska A; Gruszecki WI
    Nanomedicine; 2016 May; 12(4):1095-1103. PubMed ID: 26772425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of Luliconazole Against Broad-Range Filamentous Fungi Including Fusarium solani Species Complex Causing Fungal Keratitis.
    Todokoro D; Suzuki T; Tamura T; Makimura K; Yamaguchi H; Inagaki K; Akiyama H
    Cornea; 2019 Feb; 38(2):238-242. PubMed ID: 30422866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fungal keratitis caused by
    Dudeja L; Jeganathan L; Prajna NV; Prajna L
    Indian J Med Microbiol; 2018; 36(1):140-142. PubMed ID: 29735846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a Poly-ε-Lysine Contact Lens as a Drug Delivery Device for the Treatment of Fungal Keratitis.
    Gallagher AG; McLean K; Stewart RMK; Wellings DA; Allison HE; Williams RL
    Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4499-4505. PubMed ID: 28873175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-aggregated nanoparticles based on amphiphilic poly(lactic acid)-grafted-chitosan copolymer for ocular delivery of amphotericin B.
    Zhou W; Wang Y; Jian J; Song S
    Int J Nanomedicine; 2013; 8():3715-28. PubMed ID: 24106427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re-appraisal of topical 1% voriconazole and 5% natamycin in the treatment of fungal keratitis in a randomised trial.
    Sharma S; Das S; Virdi A; Fernandes M; Sahu SK; Kumar Koday N; Ali MH; Garg P; Motukupally SR
    Br J Ophthalmol; 2015 Sep; 99(9):1190-5. PubMed ID: 25740805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell penetrating peptides as efficient nanocarriers for delivery of antifungal compound, natamycin for the treatment of fungal keratitis.
    Jain A; Shah SG; Chugh A
    Pharm Res; 2015 Jun; 32(6):1920-30. PubMed ID: 25467959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and Characterization of Fusarium proliferatum, a New Species of Fungi that Cause Fungal Keratitis.
    Sun S; Lui Q; Han L; Ma Q; He S; Li X; Zhang H; Zhang J; Liu X; Wang L
    Sci Rep; 2018 Mar; 8(1):4859. PubMed ID: 29559666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Keratitis-associated fungi form biofilms with reduced antifungal drug susceptibility.
    Zhang X; Sun X; Wang Z; Zhang Y; Hou W
    Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7774-8. PubMed ID: 23099491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antifungal activity of amphotericin B conjugated to carbon nanotubes.
    Benincasa M; Pacor S; Wu W; Prato M; Bianco A; Gennaro R
    ACS Nano; 2011 Jan; 5(1):199-208. PubMed ID: 21141979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic response time of topical voriconazole 1% and intrastromal voriconazole 0.05% versus topical natamycin 5% monotherapy in Fusarium keratitis in rabbit.
    Edwar L; Janna YM; Rozaliyani A; Louisa M
    Mycoses; 2020 Oct; 63(10):1128-1132. PubMed ID: 32780874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chitosan functionalized poly (ε-caprolactone) nanoparticles for amphotericin B delivery.
    Vásquez Marcano RGDJ; Tominaga TT; Khalil NM; Pedroso LS; Mainardes RM
    Carbohydr Polym; 2018 Dec; 202():345-354. PubMed ID: 30287009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biodegradable functional polycarbonate micelles for controlled release of amphotericin B.
    Wang Y; Ke X; Voo ZX; Yap SSL; Yang C; Gao S; Liu S; Venkataraman S; Obuobi SAO; Khara JS; Yang YY; Ee PLR
    Acta Biomater; 2016 Dec; 46():211-220. PubMed ID: 27686042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced in vivo antifungal activity of novel cell penetrating peptide natamycin conjugate for efficient fungal keratitis management.
    Rohira H; Shankar S; Yadav S; Shah SG; Chugh A
    Int J Pharm; 2021 May; 600():120484. PubMed ID: 33737097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.